- Home
- MDXG vs EVV Comparison
MDXG vs EVV Comparison
Compare MDXG & EVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDXG
- EVV
- Stock Information
- Founded
- MDXG 2006
- EVV 2003
- Country
- MDXG United States
- EVV United States
- Employees
- MDXG N/A
- EVV N/A
- Industry
- MDXG Biotechnology: Pharmaceutical Preparations
- EVV Finance/Investors Services
- Sector
- MDXG Health Care
- EVV Finance
- Exchange
- MDXG Nasdaq
- EVV Nasdaq
- Market Cap
- MDXG 1.1B
- EVV 1.2B
- IPO Year
- MDXG N/A
- EVV N/A
- Fundamental
- Price
- MDXG $6.94
- EVV $10.20
- Analyst Decision
- MDXG Buy
- EVV
- Analyst Count
- MDXG 1
- EVV 0
- Target Price
- MDXG $12.00
- EVV N/A
- AVG Volume (30 Days)
- MDXG 439.7K
- EVV 323.7K
- Earning Date
- MDXG 10-29-2025
- EVV 01-01-0001
- Dividend Yield
- MDXG N/A
- EVV 9.66%
- EPS Growth
- MDXG N/A
- EVV N/A
- EPS
- MDXG 0.21
- EVV N/A
- Revenue
- MDXG $363,774,000.00
- EVV N/A
- Revenue This Year
- MDXG $12.68
- EVV N/A
- Revenue Next Year
- MDXG $8.18
- EVV N/A
- P/E Ratio
- MDXG $32.78
- EVV N/A
- Revenue Growth
- MDXG 6.85
- EVV N/A
- 52 Week Low
- MDXG $5.47
- EVV $8.52
- 52 Week High
- MDXG $10.14
- EVV $10.07
- Technical
- Relative Strength Index (RSI)
- MDXG 46.17
- EVV 44.81
- Support Level
- MDXG $6.89
- EVV $10.18
- Resistance Level
- MDXG $7.14
- EVV $10.29
- Average True Range (ATR)
- MDXG 0.18
- EVV 0.07
- MACD
- MDXG -0.04
- EVV -0.02
- Stochastic Oscillator
- MDXG 29.55
- EVV 8.70
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
About EVV Eaton Vance Limited Duration Income Fund of Beneficial Interest
Eaton Vance Ltd Duration Income Fund is a diversified closed-end management investment company. The company's investment objective is to provide a high level of current income. The Fund also seeks capital appreciation. The Fund invests predominantly in Senior Floating-Rate Loans, Debt Obligations, Equity Securities, Derivatives as well as Foreign Securities and Currencies. The Fund invests in various industries, including aerospace and defense, automotive, building and development, healthcare, and leisure, among others.